Netherlands Federation of University Medical Centres (NFU)
Academic / research · Netherlands · EU Transparency Register 256616021093-07not in register snapshot
identity not settledMore than one register entry could match this filer, so we have not linked it to any of them. The filings shown are those under this exact name.
This register number is the organization’s own declaration on its submission. It is not in the 30 Sept 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.
3
positions filed
in the 655 files tracked
2
legislative files
of 655 tracked
3
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 655 consultation files tracked so far (56,999 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Work at Netherlands Federation of University Medical Centres (NFU)? so we know who speaks for it.
Their record over time
Netherlands Federation of University Medical Centres (NFU) filed 3 positions between 30 Jun 2023 and 6 Nov 2025, across 2 of the 655 legislative files tracked here, attaching a full position paper 3 times.
NFU position on the EU FP10 proposal (MFF consultation) To European Commission From NFU Date 6-11-2025 Our reference 25.01356/P. Drankier The Future of Health Research & Innovation: NFU reaction to the FP10 proposal The Netherlands Federation of University Medical Centres (NFU) is cautiously optimistic upon a first analysis of the forthcoming Multiannual Financial Framework (MFF), the next Framework Programme for…
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
NFU position on the EU FP10 proposal (MFF consultation) To European Commission From NFU Date 6-11-2025 Our reference 25.01356/P. Drankier The Future of Health Research & Innovation: NFU reaction to the FP10 proposal The Netherlands Federation of University Medical Centres (NFU) is cautiously optimistic upon a first analysis of the forthcoming Multiannual Financial Framework (MFF), the next Framework Programme for…
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The development of new and innovative pharmaceutical products has become much more research intensive. Most products available are the result of academia delivering new knowledge based on biomedical and chemical research and pharmaceutical companies further developing those novel insights into safe and effective products.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Netherlands Federation of University Medical Centres (NFU) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Everything on this page comes from Netherlands Federation of University Medical Centres (NFU)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.
